Cargando…
Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma
SIMPLE SUMMARY: Liver transplantation is a curative treatment option for a subset of patients with hepatocellular carcinoma (HCC). However, about twenty percent of patients develop recurrence in the graft or at extrahepatic sites, which is associated with limited therapeutic options and poor surviva...
Autores principales: | Ossami Saidy, Ramin Raul, Postel, Maximilian Paul, Pflüger, Michael Johannes, Schoening, Wenzel, Öllinger, Robert, Gül-Klein, Safak, Schmelzle, Moritz, Tacke, Frank, Pratschke, Johann, Eurich, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037838/ https://www.ncbi.nlm.nih.gov/pubmed/33807392 http://dx.doi.org/10.3390/cancers13071617 |
Ejemplares similares
-
The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation
por: Gül-Klein, Safak, et al.
Publicado: (2022) -
Successful implementation of preventive measures leads to low relevance of SARS‐CoV‐2 in liver transplant patients: Observations from a German outpatient department
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2020) -
Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021) -
How to Estimate the Probability of Tolerance Long-Term in Liver Transplant Recipients
por: Eurich, Dennis, et al.
Publicado: (2023) -
Clinical and Histological Long-Term Follow-Up of De Novo HBV-Infection after Liver Transplantation
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)